Granite Investment Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-25,572
Closed -$2.12M 302
2020
Q1
$2.12M Sell
25,572
-885
-3% -$86.3K 0.14% 153
2019
Q4
$2.94M Buy
26,457
+9,608
+57% +$988K 0.14% 150
2019
Q3
$1.67M Buy
16,849
+339
+2% +$33.7K 0.09% 173
2019
Q2
$1.64M Buy
16,510
+5,084
+44% +$485K 0.09% 174
2019
Q1
$1.26M Sell
11,426
-943
-8% -$98.6K 0.07% 183
2018
Q4
$1.14M Buy
+12,369
New +$1.25M 0.08% 156

Other funds holding PRAH

Granite Investment Partners's PRAH Position: Q2 2020 in Review

Granite Investment Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 25,572 shares — an estimated $2.12M sold.

Granite Investment Partners first reported a position in PRAH in Q4 2018 and held it in 6 quarters. The position peaked at $2.94M in Q4 2019. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Granite Investment Partners reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Granite Investment Partners sold 25,572 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $2.12M.
  • Granite Investment Partners first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 6 quarters.
  • Granite Investment Partners's PRA Health Sciences, Inc. position peaked at $2.94M in Q4 2019.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Granite Investment Partners's 13F filing for Q2 2020, filed 3 Aug 2020.